CorrlensCorrlens
Correlate

Correlation Analysis

Broadcom Inc. Common Stock vs Alnylam Pharmaceuticals, Inc.

AVGO vs ALNY

+0.882

Very strong positive

When one moves up, the other tends to follow.

AVGO logo

Broadcom Inc. Common Stock

AVGO

Broadcom is one of the largest semiconductor companies in the world and has also expanded into infrastructure software. Its semiconductors primarily serve computing and networking, with custom AI accelerators now accounting for the bulk of the business. It is primarily a fabless designer, but holds some manufacturing in-house, such as for its best-of-breed film bulk acoustic resonator filters that sell into the Apple iPhone. In software, it sells virtualization, infrastructure, and security software to large enterprises, financial institutions, and governments. Broadcom is the product of consolidation. Its businesses are an amalgamation of former companies like legacy Broadcom and Avago Technologies in chips, as well as VMware, Brocade, CA Technologies, and Symantec in software.

Market cap 1.5T

ALNY logo

Alnylam Pharmaceuticals, Inc.

ALNY

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam's commercial RNAi therapeutic products include Onpattro and Amvuttra (for hATTR amyloidosis), Givlaari (for acute hepatic porphyria), and Oxlumo (for primary hyperoxaluria type 1), all developed and commercialized by Alnylam. Plus, Leqvio (for hypercholesterolemia) and Qfitlia (for hemophilia A or B), which are being commercialized by Alnylam's partners, Novartis and Sanofi, respectively. It also has several clinical programs across various therapeutic areas, including cardio-metabolic diseases, neuroscience, and hematology.

Market cap 43.8B · 2,500 employees

Apr 9, 2021 — Apr 7, 2026Daily1,253 observationsStockStockTechnology

Time Series

Rebased to 100

Green: AVGOGray: ALNY36 of 1,253 points (sampled)

Who Moves First

ALNY leads AVGO by 4 days

ALNY tends to move before AVGO.

Best correlation after shifting: +0.883 (13 shifts scanned)

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

+0.566

15 periods · Return correlation when both series rose

Both Falling

-0.022

8 periods · Return correlation when both series fell

Diverging

-0.803

12 periods · Return correlation when series moved apart

R-Squared

77.8%

Share of variance in one series explained by the other.

Trend Agreement

55.6%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,253

Deep shared window — 1,253 usable pairs.

Significance

p < 0.001

95% CI: [0.869, 0.894]

Scatter

XY Regression

2010020030040040398100200300400497Broadcom Inc. Common StockAlnylam Pharmaceuticals, Inc.Data pointsFit (r = 0.882)

Pipeline

Data quality details

Pipeline Summary

1,253 paired observations survived the daily window.

Raw input

1,254

1,253

Normalized

1,254

1,253

Prepared

1,254

1,253

Aligned

1,253

1,253

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

1

A: 1 / B: 0

Series A

AVGO logo

Broadcom Inc. Common Stock

AVGO

Market cap 1.5T

Stock · 1,254 raw → 1,254 prepared

Series B

ALNY logo

Alnylam Pharmaceuticals, Inc.

ALNY

Market cap 43.8B · 2,500 employees

Stock · 1,253 raw → 1,253 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

54

Estimated crossover points between normalized spreads.

Slope

0.7566

Linear regression slope.

Intercept

125.6588

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 3 hours ago · ID: stock-avgo-vs-stock-alny-daily-20260408-emq3er